Nanoparticulate drugs for the manipulation of angiogenesis

Author： Millar Timothy M Kanaras Antonios G

ISSN： 2041-5990

Source： Therapeutic Delivery, Vol.4, Iss.10, 2013-10, pp. : 1217-1219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of New Drugs in Angiogenesis

Current Drug Targets, Vol. 5, Iss. 5, 2004-07 ,pp. : 485-493

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenesis Drugs in Diabetic Retinopathy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 369-372

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 3, 2017-04 ,pp. : 303-310

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

Current Pharmaceutical Design, Vol. 13, Iss. 20, 2007-07 ,pp. : 2074-2086

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis: New Opportunities and Solutions for Drug Development. Predictive markers for antiangiogenic drugs

By Gerber Hans-Peter

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 2001-2004

Informa Healthcare

Access to resources Recommend Favorite